Subcutaneous Drug Delivery Market to Surpass US$ 15.8 Billion by 2026 - Coherent Market Insights

Published On : Jul 30, 2019

Global Subcutaneous Drug Delivery Market, by Usability (Disposable and Reusable), by Disease Indication (Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy and Infectious Disorders, Ophthalmic Disorders, and Others), by Delivery Type (Prefilled Syringe, Injector, Prefilled Pen, Vial (Syringe), Pump and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 7,077.5 million in 2017 and is projected to exhibit a CAGR of 9.5% over the forecast period (2018–2026), as highlighted in a new report published by Coherent Market Insights.

Prefilled syringes are ready-to-use disposable syringes that contain premeasured dosage. It reduces dosing errors and increases patient compliance, dosing accuracy, convenience, and safety.

Combination products, particularly injectable drug delivery systems such as prefilled syringes are largely being adopted, with increasing number of injectable biological drugs, by healthcare professionals, owing to higher convenience.

According to the study named Growth & Benefits of Pre-Filled Syringes by Fisher Clinical Service, 2014, around 13 biotechnology products were available commercially in the market in 1989, which increased to 210 in 2012. As per Fisher Clinical Service, in 2013, the prefilled syringes segment was expected to account for a quarter of the total injectables drug delivery systems, which included around 35 of the 100 top-selling drugs, which were to be incorporated in the form of injection.

In December 2016, Becton, Dickinson and Company announced the launch of BD Neopak 2.25 mL prefillable glass syringe, which is developed for biopharmaceutical manufacturers focused on manufacturing of sensitive biologic drugs for the treatment of chronic diseases such as rheumatoid arthritis, psoriasis, lupus, and severe asthma. The syringe offers higher volume subcutaneous injections, thereby helping to improve safety and convenience for patients.

Browse 36 Market Data Tables and 30 Figures spread through 237 Pages and in-depth TOC on “Subcutaneous Drug Delivery Market”- Global Forecast to 2026, by Usability (Disposable and Reusable), by Disease Indication (Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy and Infectious Disorders, Ophthalmic Disorders, and Others), by Delivery Type (Prefilled Syringe, Injector, Prefilled Pen, Vial (Syringe), Pump, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa),

To know the latest trends and insights prevalent in the global subcutaneous drug delivery market, click the link below:

https://www.coherentmarketinsights.com/market-insight/subcutaneous-drug-delivery-market-2933

Small companies are focused on development of novel epinephrine auto injectors, which offer thermal stability. Currently available products work optimally at specific temperatures, thereby providing a growth opportunity for manufacturers in the global subcutaneous drug delivery market. For instance, Windgap Medical is focused on developing a portable device that would mix a dry formulation of the drug into solution, thus providing temperature stability and a longer shelf-life of medication, for patients suffering from anaphylaxis due to an acute allergy attack.

Key Takeaways of the Global Subcutaneous Drug Delivery Market:     

  • The global subcutaneous drug delivery market is expected to exhibit a CAGR of 9.5% over the forecast period, owing to increasing chronic diseases, adoption of novel drug delivery technologies to reduce needlestick injuries, and increasing product offerings by market players
  • Among usability, disposable segment held a higher market share in 2018, owing to significant increase in self-administration of drugs to treat chronic diseases
  • Among disease indication, autoimmune disorders segment held a higher market share in 2018, owing to rising prevalence of autoimmune diseases such as multiple sclerosis and new approvals for injector devices
  • Companies operating in the global subcutaneous drug delivery market include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Sanofi S.A., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, and Merck & Co., Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.